background image

Paid Clinical Trials Nashville

Discover 1,221 paid clinical trials in Nashville, Tennessee. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

Saruparib

Recruiting
PHASE3

Sponsor:

AstraZeneca

Location:

Nashville TN, Louisville KY, Lexington KY, Germantown TNshow 114 more

Code:

NCT06120491

Conditions

Metastatic Castration-Sensitive Prostate Cancer

Eligibility Criteria

Sex: Male

Age: 18 - 70+

Healthy Volunteers: Not accepted

Interventions

Saruparib

Placebo

Abiraterone Acetate

Darolutamide

Enzalutamide

P-CD19CD20-ALLO1

Recruiting
PHASE1

Sponsor:

Poseida Therapeutics, Inc.

Location:

Nashville TN, Cincinnati OH, Greenville SC, Chapel Hill NCshow 5 more

Code:

NCT06014762

Conditions

Diffuse Large B-Cell Lymphoma, Not Otherwise Specified

High-grade B-cell Lymphoma

Primary Mediastinal Large B-cell Lymphoma (PMBCL)

Transformed Follicular Lymphoma (tFL)

Follicular Lymphoma Grade 3B

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

P-CD19CD20-ALLO1

Rimiducid

Factor Xa Inhibition

Recruiting

Sponsor:

Vanderbilt University Medical Center

Location:

Nashville TN

Code:

NCT05009862

Conditions

Peripheral Arterial Disease

Eligibility Criteria

Sex: All

Age: 40+

Healthy Volunteers: Not accepted

Interventions

Rivaroxaban 2.5 Mg Oral Tablet

Placebo

Aspirin 81Mg Ec Tab

GEN1057

Recruiting
PHASE1

Sponsor:

Genmab

Location:

Nashville TN, San Antonio TX

Code:

NCT06573294

Conditions

Advanced Malignant Solid Tumor

Metastatic Malignant Solid Tumor

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

GEN1057

ZEN-3694 & Pembrolizumab

Recruiting
PHASE1

Sponsor:

National Cancer Institute (NCI)

Location:

Nashville TN, Columbus OH, Boston MA

Code:

NCT05422794

Conditions

Anatomic Stage III Breast Cancer AJCC v8

Anatomic Stage IV Breast Cancer AJCC v8

Locally Advanced Triple-Negative Breast Carcinoma

Metastatic Triple-Negative Breast Carcinoma

Unresectable Triple-Negative Breast Carcinoma

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

BET Bromodomain Inhibitor ZEN-3694

Biopsy

Biospecimen Collection

Computed Tomography

Magnetic Resonance Imaging

AZD8421

Recruiting
PHASE1
PHASE2

Sponsor:

AstraZeneca

Location:

Nashville TN, Saint Louis MO, Houston TX, Providence RI

Code:

NCT06188520

Conditions

ER+ HER2- Advanced Breast Cancer

High-grade Serous Ovarian Cancer (HGSOC)

Eligibility Criteria

Sex: Female

Age: 18+

Healthy Volunteers: Not accepted

Interventions

AZD8421

Camizestrant

Ribociclib

Palbociclib

Abemaciclib

GIM-122

Recruiting
PHASE1
PHASE2

Sponsor:

Georgiamune Inc

Location:

Nashville TN, Louisville KY, Richmond VA, Dallas TXshow 5 more

Code:

NCT06028074

Conditions

Advanced Solid Malignancies

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

GIM122

Midodrine vs. Abdominal Compression

Recruiting
EARLY_PHASE1

Sponsor:

Vanderbilt University Medical Center

Location:

Nashville TN

Code:

NCT04620382

Conditions

Neurogenic Orthostatic Hypotension

Autonomic Failure

Pure Autonomic Failure

Multiple System Atrophy

Parkinson Disease

Eligibility Criteria

Sex: All

Age: 40 - 70+

Healthy Volunteers: Not accepted

Interventions

Midodrine

Placebo pill

Abdominal compression

sham compression

BIIB091 & DRF

Recruiting
PHASE2

Sponsor:

Biogen

Location:

Nashville TN, Cordova TN, Cincinnati OH, Saint Louis MOshow 19 more

Code:

NCT05798520

Conditions

Relapsing Forms of Multiple Sclerosis

Eligibility Criteria

Sex: All

Age: 18 - 55

Healthy Volunteers: Not accepted

Interventions

BIIB091

DRF

Placebo

N-acetylcysteine

Recruiting
PHASE3

Sponsor:

Johns Hopkins University

Location:

Nashville TN, Atlanta GA, Chicago IL, Evanston ILshow 21 more

Code:

NCT05537220

Conditions

Retinitis Pigmentosa

Eligibility Criteria

Sex: All

Age: 18 - 65

Healthy Volunteers: Not accepted

Interventions

N-acetylcysteine

Placebo